Cover ImageSALE
Market Research Report

Global Prenatal DNA Sequencing Market 2018-2022

Published by TechNavio (Infiniti Research Ltd.) Product code 640157
Published Content info 121 Pages
Immediate Delivery Available
Price
Back to Top
Global Prenatal DNA Sequencing Market 2018-2022
Published: April 16, 2018 Content info: 121 Pages
Description

About Prenatal DNA Sequencing

Prenatal DNA sequencing is the method of DNA sequencing where DNA isolated from the blood of pregnant women to reveal the full genetic code of a fetus. It is useful in detecting disorders such as Down syndrome, cystic fibrosis, thalassemia, and cancer.

Technavio's analysts forecast the global prenatal DNA sequencing market to grow at a CAGR of 13.50% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the global prenatal DNA sequencing market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Prenatal DNA Sequencing Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Agilent Technologies
  • BGI
  • F. Hoffmann-La Roche
  • Illumina
  • Laboratory Corporation of America
  • Natera

Market driver

  • Increasing prevalence of cancer
  • For a full, detailed list, view our report

Market challenge

  • High cost of sequencing
  • For a full, detailed list, view our report

Market trend

  • Growing technological improvements in DNA sequencing
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents
Product Code: IRTNTR21138

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 05: MARKET SIZING

  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: MARKET SEGMENTATION BY APPLICATION

  • Segmentation by application
  • Comparison by application
  • Genetic diseases
  • Non-genetic diseases
  • Market opportunity by application

PART 08: CUSTOMER LANDSCAPE

PART 09: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • Americas
  • EMEA
  • APAC
  • Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 12: MARKET TRENDS

  • Increasing number of research activities on human genomics
  • Growing technological improvements in DNA sequencing
  • Increasing M&A

PART 13: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 14: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Agilent Technologies
  • BGI
  • F. Hoffmann-La Roche
  • Illumina
  • Laboratory Corporation of America
  • Natera
  • Other prominent vendors

PART 15: APPENDIX

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Parent market
  • Exhibit 02: Global DNA sequencing market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Market size 2017
  • Exhibit 07: Validation techniques employed for market sizing 2017
  • Exhibit 08: Global prenatal DNA sequencing market 2017-2022 ($ mn)
  • Exhibit 09: Global prenatal DNA sequencing market - Year-over-year growth 2018-2022 (%)
  • Exhibit 10: Five forces analysis 2017
  • Exhibit 11: Five forces analysis 2022
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2017
  • Exhibit 18: Market condition - Five forces 2022
  • Exhibit 19: Global prenatal DNA sequencing market by application - Market share 2017-2022 (%)
  • Exhibit 20: Comparison by application
  • Exhibit 21: Common types of genetic disorders
  • Exhibit 22: Global prenatal DNA sequencing market by genetic diseases - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 23: Global prenatal DNA sequencing market by genetic diseases - Year-over-year growth 2018-2022 (%)
  • Exhibit 24: Global prenatal DNA sequencing market by non-genetic diseases - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 25: Global prenatal DNA sequencing market by non-genetic diseases - Year-over-year growth 2018-2022 (%)
  • Exhibit 26: Market opportunity by application
  • Exhibit 27: Customer landscape
  • Exhibit 28: Global - Market share by geography 2017-2022 (%)
  • Exhibit 29: Regional comparison
  • Exhibit 30: Americas - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 31: Americas - Year-over-year growth 2018-2022 (%)
  • Exhibit 32: Top 3 countries in Americas
  • Exhibit 33: EMEA - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 34: EMEA - Year-over-year growth 2018-2022 (%)
  • Exhibit 35: Top 3 countries in EMEA
  • Exhibit 36: APAC - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 37: APAC - Year-over-year growth 2018-2022 (%)
  • Exhibit 38: Top 3 countries in APAC
  • Exhibit 39: Market opportunity
  • Exhibit 40: R&D funding for cancer 2013-2016 ($ millions)
  • Exhibit 41: Cost of sequencing per genome 2001-2015 ($)
  • Exhibit 42: Prominent M&A in DNA sequencing market 2007-2014
  • Exhibit 43: Vendor landscape
  • Exhibit 44: Landscape disruption
  • Exhibit 45: Vendors covered
  • Exhibit 46: Vendor classification
  • Exhibit 47: Market positioning of vendors
  • Exhibit 48: Agilent Technologies overview
  • Exhibit 49: Agilent Technologies - Business segments
  • Exhibit 50: Agilent Technologies - Organizational developments
  • Exhibit 51: Agilent Technologies - Geographic focus
  • Exhibit 52: Agilent Technologies - Segment focus
  • Exhibit 53: Agilent Technologies - Key offerings
  • Exhibit 54: BGI: Overview
  • Exhibit 55: BGI: Business segments
  • Exhibit 56: BGI: Organizational developments
  • Exhibit 57: BGI: Geographic focus
  • Exhibit 58: BGI: Segment focus
  • Exhibit 59: BGI: Key offerings
  • Exhibit 60: F. Hoffmann-La Roche: Overview
  • Exhibit 61: F. Hoffmann-La Roche: Business segments
  • Exhibit 62: F. Hoffmann-La Roche: Organizational developments
  • Exhibit 63: F. Hoffmann-La Roche: Geographic focus
  • Exhibit 64: F. Hoffmann-La Roche: Segment focus
  • Exhibit 65: F. Hoffmann-La Roche: Key offerings
  • Exhibit 66: Illumina: Overview
  • Exhibit 67: Illumina: Business segments
  • Exhibit 68: Illumina: Organizational developments
  • Exhibit 69: Illumina: Geographic focus
  • Exhibit 70: Illumina: Segment focus
  • Exhibit 71: Illumina: Key offerings
  • Exhibit 72: Laboratory Corporation of America overview
  • Exhibit 73: Laboratory Corporation of America - Business segments
  • Exhibit 74: Laboratory Corporation of America- Organizational developments
  • Exhibit 75: Laboratory Corporation of America - Geographic focus
  • Exhibit 76: Laboratory Corporation of America - Segment focus
  • Exhibit 77: Laboratory Corporation of America- Key offerings
  • Exhibit 78: Natera overview
  • Exhibit 79: Natera - Business segments
  • Exhibit 80: Natera- Organizational developments
  • Exhibit 81: Natera - Geographic focus
  • Exhibit 82: Natera - Segment focus
  • Exhibit 83: Natera - Key offerings
Back to Top